Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REST: Trazodone for Sleep and Cognition in Early Alzheimer's Disease
NCT05282550Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Feb 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trazodone hydrochloride prolonged-release tablets in amnestic mild cognitive impairment (MCI), sleep disorder, sponsored by Johns Hopkins University. Started Feb 2023; status: recruiting.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
amnestic mild cognitive impairment (MCI)sleep disorder
Beyond the preview
Go deeper on NCT05282550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05282550.